By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Merck Eprova AG 

Schaffhauserstrasse 136

Glattbrugg    8152  Switzerland
Phone: 41-1-828-7111 Fax: 41-1-828-7210



Company News
Merck Eprova AG and Isofol Medical Enter Exclusive Agreement for Merck Eprova's Modufolin(R) in Oncology 11/11/2009 2:15:07 PM
PDS Biotechnology Corporation Finalizes Commercial Licensing Agreement with Merck Eprova AG 2/24/2009 11:00:18 AM
Merck Eprova AG Highlighted For Inventing Metafolin(R) With The Frost & Sullivan Product Differentiation Innovation Award Of The Year 1/9/2007 9:57:31 AM
EMD Chemicals, Inc. (MRK) Announces New President And CEO 11/2/2006 11:25:49 AM
BioMarin Pharmaceutical Inc. (BMRN) Initiates Phase 3 Clinical Trial Of Phenoptin For PKU10/19/2005 5:13:14 PM
Merck & Co., Inc. (MRK) Innovates With Equant; Merck KGaA (MKGAF.PK) Signs New Three-Year Agreement For Customized IP VPN Solution 10/19/2005 5:12:30 PM
Hagens Berman Release: Arizona Consumer Files First Class Action Against Vioxx Manufacturer Merck & Co., Inc. (MRK)10/19/2005 5:12:26 PM
Merck & Co., Inc. (MRK) Sued By Wechsler Harwood LLP10/19/2005 5:12:26 PM
Biomira Inc. (BIOM) And Merck KGaA (MKGAF.PK) Present Non-Small Cell Lung Cancer Data At European Society For Medical Oncology Congress (Abstract No. 3IN)10/19/2005 5:12:02 PM
Xenogen Corporation (XGEN) Announces Five-Year Global Licensing Agreement With Merck & Co. (MRK)10/19/2005 5:11:49 PM